Homicide Ruling in Bronx Woman's Death After Fake Anti-aging Treatment

WHO:

NY Post - Elizabeth Baron is the deceased woman involved in the case.

Gothamist - An unlicensed practitioner at Bereshit Lifestyle Center administered the treatment.

WHAT:

NY Post - Elizabeth Baron's cause of death has been revealed as linked to the NAD+ infusion she received.

Gothamist - Elizabeth Baron's death has been ruled a homicide by the medical examiner.

NY Post - Baron received an NAD+ infusion, which is a trendy anti-aging treatment.

WHERE:

Gothamist - The incident took place at Bereshit Lifestyle Center located in Kingsbridge, Bronx, New York.

WHEN:

Gothamist - The NAD+ infusion was administered in July.

WHY:

NY Post - The treatment was administered by an unlicensed practitioner, which has led to homicide charges against the individual involved.

Gothamist - The cause of death was linked to the unlicensed administration of the anti-aging treatment.

HOW:

Gothamist - The unlicensed practitioner at Bereshit Lifestyle Center has been charged with homicide following the incident.

Gothamist - The treatment involved an NAD+ infusion, which was given by an unlicensed practitioner.

(UPDATED September 22, 2026 19:01 UTC)

Elizabeth Baron's cause of death has been linked to an NAD+ infusion she received from an unlicensed practitioner. This has resulted in homicide charges against the individual who administered the treatment at the Bereshit Lifestyle Center. Authorities are taking this matter seriously as they investigate the circumstances surrounding her tragic death.

--

(UPDATED September 22, 2026 18:00 UTC)

Elizabeth Baron has been identified as the deceased woman whose death has been ruled a homicide by the medical examiner following an NAD+ infusion administered at the Bereshit Lifestyle Center in Kingsbridge, Bronx, New York. The treatment, which is popular for its anti-aging properties, was given by an unlicensed practitioner in July. Authorities have linked the cause of her death to the unlicensed administration of this controversial treatment.